We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Vor Biopharma Inc | NASDAQ:VOR | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.105 | -6.12% | 1.61 | 1.61 | 1.62 | 1.73 | 1.54 | 1.72 | 312,499 | 19:59:11 |
Citi’s 2023 18th Annual BioPharma Conference1x1 Investor Meetings: Thursday, September 7, 2023 Location: Four Seasons Hotel, Boston, MA
H.C. Wainwright 25th Annual Global Investment Conference (Hybrid)Virtual Presentation: Monday, September 11, 2023 Location: Lotte New York Palace Hotel, New York, NY
Baird’s 2023 Global Healthcare Conference Presentation: Wednesday, September 13, 2023 at 9:05 am ETLocation: Intercontinental New York Barclay, New York, NY
Morgan Stanley 21st Annual Global Healthcare ConferenceFireside Chat: Wednesday, September 13, 2023 at 4:15 pm ETLocation: Sheraton Hotel, New York, NY
Live webcasts and archived replays of the presentation at the H.C. Wainwright 25th Annual Global Investment Conference and the fireside chat at the Morgan Stanley 21st Annual Global Healthcare Conference will be available on the investors section of www.vorbio.com.
About Vor BioVor Bio is a clinical-stage cell and genome engineering company that aims to change the standard of care for patients with blood cancers by engineering hematopoietic stem cells to enable targeted therapies post-transplant. For more information, visit: www.vorbio.com.
Contact:
Media & InvestorsSarah Spencer +1 857-242-6076sspencer@vorbio.com
1 Year Vor Biopharma Chart |
1 Month Vor Biopharma Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions